# Ignacio Durán

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ignacio-duran/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,510 |
| Field | Bladder and Urothelial Cancer Treatments |
| h-index | 54 |
| i10-index | 129 |
| Last Known Institution | Marqués de Valdecilla University Hospital |
| OpenAlex ID | https://openalex.org/A5036620887 |
| ORCID iD | https://orcid.org/0000-0001-8571-7163 |
| Works | 338 |

## Researcher papers

- [Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/durvalumab-alone-and-durvalumab-plus-tremelimumab-versus-chemotherapy-in/)
- [Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-report-of-the-advanced/)
- [A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas](https://scholariq.org/papers/a-phase-ii-clinical-and-pharmacodynamic-study-of-temsirolimus-in-advanced/)
- [Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022](https://scholariq.org/papers/management-of-patients-with-advanced-prostate-cancer-metastatic-and-or/)
- [Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)](https://scholariq.org/papers/challenges-and-opportunities-of-cfdna-analysis-implementation-in-clinical/)

## Researcher topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies-2/)

## Researcher university

- [Marqués de Valdecilla University Hospital](https://scholariq.org/institutions/marques-de-valdecilla-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.